Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00207220 · ClinicalTrials.gov registry record
Ventricular-Vascular Coupling in Heart Failure
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 53
- Enrollment target
NCT00207220: Completed study, sponsored by Brigham and Women's Hospital.
NCT00207220 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00207220 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
This study will test the hypothesis that increases in ventricular-vascular stiffness can be demonstrated by arterial tonometry and echocardiography in subjects with heart failure with preserved ejection fraction (HF-nlEF)(i.e. normal left ventricular function.) We will also track changes in pulsatile hemodynamics over time in subjects hospitalized with HF-nlEF.
Interventions
- PROCEDURE echocardiography
- PROCEDURE arterial tonometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-01 |
What the finished NCT00207220 record still lists
NCT00207220 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which echocardiography is the first listed.
NCT00207220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00207220 about?
NCT00207220 is a clinical study titled "Ventricular-Vascular Coupling in Heart Failure". This study will test the hypothesis that increases in ventricular-vascular stiffness can be demonstrated by arterial tonometry and echocardiography in subjects with heart failure with preserved ejection fraction (HF-nlEF)(i.e. normal left ventricular function.) We will also track changes in pulsatil...
What is the current status of trial NCT00207220?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2004-01. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00207220?
The interventions under investigation include: echocardiography (PROCEDURE), arterial tonometry (PROCEDURE).
Who is sponsoring clinical trial NCT00207220?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia